US2005233421A1PendingUtilityA1
Fed-batch fermentation process and culture medium for the production of plasmid DNA in E. coli on a manufacturing scale
Assignee: BOEHRINGER INGELHEIM AUSTRIAPriority: Apr 8, 2004Filed: Apr 8, 2005Published: Oct 20, 2005
Est. expiryApr 8, 2024(expired)· nominal 20-yr term from priority
C12P 19/34C12N 15/1003C12N 1/20
33
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for producing plasmid DNA E. coli cells comprises a pre-culture and fed-batch process. The culture media of the batch phase and the culture medium added during the feeding phase are chemically defined. The culture medium of the feeding phase contains a growth-limiting substrate and is added, for at least a fraction of the feeding phase, at a feeding rate that follows a pre-defined exponential function, thereby controlling the specific growth rate at a pre-defined value. The process results in high yield and homogeneity of plasmid DNA.
Claims
exact text as granted — not AI-modified1 . A process for producing plasmid DNA on a manufacturing scale, said method comprised of the steps of:
a) growing E. coli cells that bear a plasmid carrying a gene of interest in a pre-culture and subsequently fermenting in a main culture; b) recovering and purifying the plasmid DNA from said main culture; wherein said main culture is a fed-batch process comprising a batch phase and a feeding phase and the culture medium of said batch phase and feeding phase being chemically defined and the culture medium of said feeding phase further comprised of a growth-limiting substrate and said culture medium being added at a feeding rate that follows, for at least a fraction of the feeding phase, a pre-defined exponential function, wherein said exponential function is F t =const*e μt , wherein F t is the flow rate [L/h] of the feed medium; μ is the specific growth rate [h −1 ], and t is the time interval [h] from start of the feeding phase.
2 . The method of claim 1 , wherein said fraction of said feeding phase during which said feeding rate follows said exponential function is such that more than about 20% of the total dry cell weight to be obtained in the feeding phase is generated during said fraction.
3 . The process of claim 1 , wherein said preculture medium is chemically defined.
4 . The process of claim 1 , using E. Coli cells with a mutation in the relA gene.
5 . The process of claim 4 , wherein the E. coli strain is K-12.
6 . The process of claim 5 , wherein the E. coli K-12 strain is JM108 or a derivative thereof.
7 . The process of claim 1 , wherein the plasmid has a ColE1-type origin of replication.
8 . The process of claim 7 , wherein the plasmid is a pUC plasmid.
9 . The process of claim 1 , wherein said exponential function is
F
t
=
μ
*
X
0
Y
X
/
S
*
C
S
*
ⅇ
μ
t
,
wherein
F t is the flow rate [L/h] of the feed medium;
X 0 is the total amount of biomass dry cell weight [g] at start of the feeding phase;
Y X/S is the biomass yield coefficient (g dry cell weight per g substrate);
C S is the concentration of said substrate in said feed medium [g/L], and
μ is the specific growth rate [h −1 ].
10 . The process of claim 1 , wherein the feeding rate is increased by continuously adding the medium following said exponential function.
11 . The process of claim 1 , wherein the feeding rate is increased in a semi-continuous mode by adding the medium step-wise following said exponential function.
12 . The process of claim 1 , wherein the feeding rate is increased in a discontinuous mode by adding the medium pulse-wise following said exponential function.
13 . The process of claim 1 , wherein the exponential function of the feeding rate is based on measurements of the amount of biomass.
14 . The process of claim 1 , wherein the growth limiting substrate is a carbon source.
15 . The process of claim 14 , wherein said carbon source is glucose.
16 . The process of claim 1 , wherein the growth rate is about. 0.03 to about 0.2 h −1 .
17 . The process of claim 1 , wherein the medium of the batch culture is comprised of isoleucine.
18 . The process of claim 17 , wherein the medium of the feeding phase is comprised of isoleucine.
19 . The process of claim 1 , wherein the medium of the batch culture at the start of fermentation is comprised of ammonium salts as the nitrogen source.
20 . The process of claim 19 , wherein the ammonium salt is ammonium chloride.
21 . The method of claim 1 , wherein the pH value of the main culture is adjusted by addition of ammonium hydroxide.
22 . The process of claim 1 , wherein said culture media are free of antibiotics.
23 . The process of claim 22 , wherein the culture media used in the pre-culture is free of antibiotics.
24 . A culture medium for producing plasmid DNA in E. coli on a manufacturing scale, which is a chemically defined medium that is comprised of
a) an organic carbon source selected from glucose, glycerol, fructose, lactose, sucrose, arabinose, or a mixture thereof; b) an anorganic nitrogen source selected from ammonium salts and ammonium hydroxide, wherein the nitrogen source is present as a component of the medium or added to the medium during fermentation; c) inorganic salts; d) optionally one or more substances that complement an auxotrophy of the E. coli strain; and e) isoleucine.
25 . The culture medium of claim 24 , which is a batch medium present at the start of a batch fermentation or at the start of the batch phase of a fed-batch fermentation and is comprised of:
a) glucose in concentration of about 10 to about 30 g/L; b) an ammonium salt or ammonium hydroxide in a concentration such that the ammonium concentration is about 0.5 to about 2 g/L; c) inorganic ions that serve as a supply with macro and micro elements; d) optionally one or more substances that complement an auxotrophy of the E. coli strain; and e) isoleucine in a concentration of about 0.1 to about 0.3 g/L.
26 . The culture medium of claim 24 , which is a feed medium that is added during the feeding phase of a fed-batch fermentation and is comprised of:
a) glucose in concentration of about 300 to about 500 g/L; a) inorganic ions that serve to supply with macro and micro elements; b) optionally one or more substances that complement an auxotrophy of the E. coli strain; and c) isoleucine in a concentration of about 6 g/L.Join the waitlist — get patent alerts
Track US2005233421A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.